Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 29, 2019 Off

Citi Appointed as Depositary Bank for Bicycle Therapeutics’ ADR Programme

By BusinessWire

LONDON–(BUSINESS WIRE)–Citi, acting through Citibank N.A., has been appointed by Bicycle Therapeutics plc, a biotechnology company pioneering a new class…

May 29, 2019 Off

Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists

By BusinessWire

Obesity is a complex disease and leading cause of morbidity and mortality and there are only insufficient treatment options available…

FDA grants supplemental nda for Allergan, Gedeon Richter’s Vraylar
May 29, 2019 Off

FDA grants supplemental nda for Allergan, Gedeon Richter’s Vraylar

By Dino Mustafić

Allergan and Gedeon Richter got the U.S. Food and Drug Administration approval for a supplemental New Drug Application (sNDA) for VRAYLAR (cariprazine) for expanded use to treat depressive episodes associated with bipolar I disorder (bipolar depression) in adults.

Ansun Biopharma opens door for patients to test its medication for certain parainfluenza virus infection
May 29, 2019 Off

Ansun Biopharma opens door for patients to test its medication for certain parainfluenza virus infection

By Dino Mustafić

Ansun Biopharma has welcomed the first patient to its Phase 3 clinical trial to test DAS181 a recombinant sialidase protein that can cleave sialic acid, the virus receptors located on the surface of epithelial cells lining the human respiratory track.

Patch-Safe from Schreiner MediPharm for storage of used transdermal patches
May 29, 2019 Off

Patch-Safe from Schreiner MediPharm for storage of used transdermal patches

By Dino Mustafić

Schreiner MediPharm developed the Patch-Safe specialty label for PS Marketing & Outsourcing GmbH, to be used for safe disposal of patches containing active ingredients.

Vor Biopharma says in journal that CD33-deficient HSCs can successfully engraft into the bone marrow of their host
May 29, 2019 Off

Vor Biopharma says in journal that CD33-deficient HSCs can successfully engraft into the bone marrow of their host

By BusinessWire

Preclinical study supports Vor’s approach for empowering targeted
immunotherapies through hematopoietic stem cell editing

Paper co-authored by Vor co-founder Dr. Siddhartha Mukherjee

May 29, 2019 Off

Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress

By BusinessWire

Teva presents 17 posters and three oral presentations at EHF 2019 highlighting long-term and FOCUS Phase IIIb study data The…

May 29, 2019 Off

Sensorion: Reporting of the General Assembly

By BusinessWire

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specialises in the development of…

May 29, 2019 Off

Sustained Bilateral Improvement from GenSight Biologics’ REVERSE Phase III Clinical Trial Represents Transformative Therapeutic Benefit for Patients, Key Opinion Leaders Conclude

By BusinessWire

Sustained, clinically meaningful bilateral improvement in visual functions 96 weeks after injection Observed bilateral improvement interpreted as clearly superior to…

May 28, 2019 Off

Harbour BioMed Enters Multi-Year HCAb Technology Licensing Agreement with a Top-Ten Global Pharma for Next Generation Human Antibody Discovery

By BusinessWire

Technology produces novel heavy chain-only antibodies for bi-specific, single domain antibodies or CAR-Ts CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands, &…

Posts pagination

Previous 1 … 3,159 3,160 3,161 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine